INDUCTION OF APOPTOSIS IN TUMOUR CELLS, EXPRESSING TOLL-LIKE RECEPTOR

摘要

FIELD: medicine.;SUBSTANCE: group of inventions relates to medicine, namely to oncology, and can be used for preparation of medication for treatment of cancer with expression of TLR3 in patient. For this purpose used is TLR3 agonist in combination with type I interferon in low dose. Impact efficiency is conditioned by synergic effect between TLR3 agonist and interferon.;EFFECT: invention allows to affect tumour due to induction of apoptosis in cancer cell TLR3 expressing.;18 cl, 14 ex, 1 dwg